These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 33815976)
1. Endothelial Dysfunction and Atherosclerosis in Patients With Autosomal Dominant Polycystic Kidney Disease. Ekinci İ; Buyukkaba M; Cinar A; Tunc M; Cebeci E; Gursu M; Kazancioglu R Cureus; 2021 Feb; 13(2):e13561. PubMed ID: 33815976 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation. Ozalper V; Kara M; Tanoglu A; Cetındaglı I; Ozturker C; Hancerlı Y; Hıra S; Kara K; Beyazıt Y; Yazgan Y Clin Rheumatol; 2017 Sep; 36(9):2071-2077. PubMed ID: 28074304 [TBL] [Abstract][Full Text] [Related]
3. The Effect of Smoking on Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease Patients with Preserved Renal Function. Gul CB; Yildiz A; Sag S; Oruc A; Ersoy A; Gullulu S Ren Fail; 2021 Dec; 43(1):1124-1129. PubMed ID: 34256663 [TBL] [Abstract][Full Text] [Related]
4. Levels of Endocan, Angiopoietin-2, and Hypoxia-Inducible Factor-1a in Patients with Autosomal Dominant Polycystic Kidney Disease and Different Levels of Renal Function. Raptis V; Bakogiannis C; Loutradis C; Boutou AK; Lampropoulou I; Intzevidou E; Sioulis A; Balaskas E; Sarafidis PA Am J Nephrol; 2018; 47(4):231-238. PubMed ID: 29597186 [TBL] [Abstract][Full Text] [Related]
5. Exercise capacity in polycystic kidney disease. Reinecke NL; Cunha TM; Heilberg IP; Higa EM; Nishiura JL; Neder JA; Almeida WS; Schor N Am J Kidney Dis; 2014 Aug; 64(2):239-46. PubMed ID: 24787761 [TBL] [Abstract][Full Text] [Related]
6. Serum Copeptin, NLPR3, and suPAR Levels among Patients with Autosomal-Dominant Polycystic Kidney Disease with and without Impaired Renal Function. Raptis V; Loutradis C; Boutou AK; Faitatzidou D; Sioulis A; Ferro CJ; Papagianni A; Sarafidis PA Cardiorenal Med; 2020; 10(6):440-451. PubMed ID: 33202410 [TBL] [Abstract][Full Text] [Related]
7. Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease. Lai S; Petramala L; Mastroluca D; Petraglia E; Di Gaeta A; Indino E; Panebianco V; Ciccariello M; Shahabadi HH; Galani A; Letizia C; D'Angelo AR Medicine (Baltimore); 2016 Jul; 95(29):e4175. PubMed ID: 27442639 [TBL] [Abstract][Full Text] [Related]
8. Early atherosclerosis in normotensive patients with autosomal dominant polycystic kidney disease: the relation between epicardial adipose tissue thickness and carotid intima-media thickness. Sag S; Yildiz A; Gullulu S; Gungoren F; Ozdemir B; Cegilli E; Oruc A; Ersoy A; Gullulu M Springerplus; 2016; 5():211. PubMed ID: 27026905 [TBL] [Abstract][Full Text] [Related]